Cargando…
Surrogate endpoint evaluation using data from one large global randomized controlled trial
BACKGROUND: Robust identification of surrogate endpoints can help accelerate the development of pharmacotherapies for diseases traditionally evaluated using true endpoints associated with prolonged follow-up. The meta-analysis-based surrogate endpoint evaluation (SEE) integrates data from multiple,...
Autores principales: | Geybels, Milan, Wolthers, Benjamin Ole, Kreiner, Frederik Flindt, Rasmussen, Sren, Bauer, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139150/ https://www.ncbi.nlm.nih.gov/pubmed/34016120 http://dx.doi.org/10.1186/s12911-021-01516-8 |
Ejemplares similares
-
Individual dynamic prediction of clinical endpoint from large dimensional longitudinal biomarker history: a landmark approach
por: Devaux, Anthony, et al.
Publicado: (2022) -
A systematic comparison of recurrent event models for application to composite endpoints
por: Ozga, Ann-Kathrin, et al.
Publicado: (2018) -
Choice of surrogate tissue influences neonatal EWAS findings
por: Lin, Xinyi, et al.
Publicado: (2017) -
A low cost surrogate eye model for corneal foreign body removal
por: Lin, Jingping, et al.
Publicado: (2020) -
Detection of large deletions in the LDL receptor gene with quantitative PCR methods
por: Damgaard, Dorte, et al.
Publicado: (2005)